中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
30期
144-145
,共2页
双氢克尿噻%安体舒通%皮炎湿疹类皮肤病
雙氫剋尿噻%安體舒通%皮炎濕疹類皮膚病
쌍경극뇨새%안체서통%피염습진류피부병
HCTZ%Spironolactone%Dermatitis and eczema
目的：探讨皮炎湿疹类皮肤病临床治疗体会。方法本次选取皮炎湿疹类皮肤病80例，随机分组，就常规方案治疗（对照组，n=40）与加用双氢克尿噻安体舒通辅助治疗（观察组，n=40）效果展开对比。结果观察组选取的皮炎湿疹类皮肤病经统计总有效率为95%，高于对照组75%，有统计学差异（P＜0.05）。两组组疗前ESR指标、RF指标、CRP指标均差异不明显（P＞0.05），疗后均有下降，但观察组幅度较对照组显著（P＜0.05）。结论皮炎湿疹类皮肤病在常规治疗基础上，取双氢克尿噻、安体舒通联合加用，对改善预后，消除临床症状，保障患者生存质量。
目的：探討皮炎濕疹類皮膚病臨床治療體會。方法本次選取皮炎濕疹類皮膚病80例，隨機分組，就常規方案治療（對照組，n=40）與加用雙氫剋尿噻安體舒通輔助治療（觀察組，n=40）效果展開對比。結果觀察組選取的皮炎濕疹類皮膚病經統計總有效率為95%，高于對照組75%，有統計學差異（P＜0.05）。兩組組療前ESR指標、RF指標、CRP指標均差異不明顯（P＞0.05），療後均有下降，但觀察組幅度較對照組顯著（P＜0.05）。結論皮炎濕疹類皮膚病在常規治療基礎上，取雙氫剋尿噻、安體舒通聯閤加用，對改善預後，消除臨床癥狀，保障患者生存質量。
목적：탐토피염습진류피부병림상치료체회。방법본차선취피염습진류피부병80례，수궤분조，취상규방안치료（대조조，n=40）여가용쌍경극뇨새안체서통보조치료（관찰조，n=40）효과전개대비。결과관찰조선취적피염습진류피부병경통계총유효솔위95%，고우대조조75%，유통계학차이（P＜0.05）。량조조료전ESR지표、RF지표、CRP지표균차이불명현（P＞0.05），료후균유하강，단관찰조폭도교대조조현저（P＜0.05）。결론피염습진류피부병재상규치료기출상，취쌍경극뇨새、안체서통연합가용，대개선예후，소제림상증상，보장환자생존질량。
eczema.Methods The selected 80 cases of dermatitis and eczema, were randomized to the conventional regimen (control group, n=40) with the addition of HCTZ spironolactone adjuvant therapy (study group, n=40) the effect of expansion were compared.Results Observation group selected dermatitis and eczema by the statistics, the total effective rate was 95%, signiifcantly higher than 75%, a signiifcant difference (P<0.05). The two groups before treatment ESR indicators, RF index, CRP indicators are not obviously differences (P>0.05), were decreased after treatment, but the magnitude of the observation group was significantly more than the control group (P<0.05).Conclusion Dermatitis and eczema in conventional therapy, taking hydrochlorothiazide, spironolactone joint plus, to improve the prognosis, eliminate clinical symptoms, meaning to protect the quality of life of patients signiifcantly.
